In the recent article by Groetch et al published online this February in the Journal of Allergy and Clinical Immunology: In Practice, the authors developed extensive guidelines for the introduction of peanut, milk, egg, wheat, cashew, hazelnut, and walnut into diet of individuals who have completed oral immunotherapy using commonly available retail foods. These guidelines include the different serving sizes that should be consumed from different retail food options to maintain allergic tolerance after immunotherapy completion. These guidelines serve as a valuable post-immunotherapy resource for clinicians and patients as previous studies have highlighted the importance of continued allergen consumption for maintaining the protection provided by oral immunotherapy. Please note that these resources should only be used by individuals who have successfully completed oral immunotherapy or equivalent immunotherapy options as safe consumption of allergic foods requires careful buildup of tolerance which should only be done under the close support of a trained medical team. These resources were developed as part of the ongoing OUtMATCH clinical trial investigating the use of omalizumab with and without oral immunotherapy for the treatment of food allergy.